Bibliometric Analysis of Multiple Sclerosis Studies in Pharmacology Journals

Abstract

Multiple sclerosis (MS) is a prevalent neurological disease with a global impact on patients' lives. Our study aimed to conduct a bibliometric analysis of research published in the field of pharmacology over the past decade. We retrieved original articles on MS from pharmacology journals in the last ten years through the Scopus database. The collected data underwent analysis using VOSViewer software, examining relationships between studies based on parameters such as citation, authorship, and organizations. In our country-based analysis, the United States emerged with the highest document count, totaling 350, followed by Germany with 210 documents. Claudio Viegas holds the top position with four publications in the last decade. The most prolific organization identified was associated with the Biogen-Cambridge-MA-United States group. However, Chulalongkorn University in Bangkok, Thailand, specifically the Department of Psychiatry, received the most citations. The most cited document was \"Therapeutic Advances in Neurological Disorders,\" while the study with the highest citations was Ferreria-Vieira et al.'s (2016) work published in Current Neuropharmacology. Research efforts on MS treatment are evidently growing, with diverse research groups contributing worldwide. We anticipate that our study will provide valuable guidance to researchers in the field by shedding light on significant research and their interconnections in recent years.